Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.

about

Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis.

P2860

Q51733178-95F6548F-7E52-48C4-B1BE-189F38A59C8D

P2860

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.

Item

http://www.wikidata.org/entity/Q47688852

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Monitoring disease progression ...... ral sclerosis clinical trials.

@en

Monitoring disease progression ...... ral sclerosis clinical trials.

@nl

type

Item

label

Monitoring disease progression ...... ral sclerosis clinical trials.

@en

Monitoring disease progression ...... ral sclerosis clinical trials.

@nl

prefLabel

Monitoring disease progression ...... ral sclerosis clinical trials.

@en

Monitoring disease progression ...... ral sclerosis clinical trials.

@nl

P1476

Monitoring disease progression ...... ral sclerosis clinical trials.

@en

P2093

Marinus J C Eijkemans

http://www.w3.org/2001/XMLSchema#string

Ruben P A van Eijk

http://www.w3.org/2001/XMLSchema#string

Stavros Nikolakopoulos

http://www.w3.org/2001/XMLSchema#string

Toby A Ferguson

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

The PRO-ACT database: design, initial analyses, and predictive features

Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature.

Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.

Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database.

Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.

Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis.

Study designs and statistical analyses for biomarker research

Statistical evaluation of biomarkers as surrogate endpoints: a literature review.

Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.

P304

156-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP-2017-317077

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Leonard H van den Berg

Jan H Veldink

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29084868

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

5800333

http://www.w3.org/2001/XMLSchema#string

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.

about

P2860

P2860

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932